Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vera Therapeutics, Inc. | Director | Class A Common Stock | 3.6M | $80.4M | $22.35 | Jun 24, 2025 | Indirect |
BioAge Labs, Inc. | Director | Common Stock | 1.71M | $30.8M | $18.00 | Sep 27, 2024 | Longitude Venture Partners IV, L.P. |
Zenas BioPharma, Inc. | Director | Common Stock | 775K | $13.2M | $17.00 | Sep 16, 2024 | Indirect |
Jazz Pharmaceuticals plc | Director | Ordinary Shares | 26.4K | $2.93M | $111.25 | Aug 8, 2025 | Direct |
Aptinyx Inc. | Director | Stock Option (Right to Buy) | 40K | May 26, 2022 | Direct | ||
BioAge Labs, Inc. | Director | Stock Option (Right to Buy) | 22K | Jun 5, 2025 | Direct | ||
Zenas BioPharma, Inc. | Director | Stock Option (Right to Buy) | 18.5K | Jun 10, 2025 | Direct | ||
Vera Therapeutics, Inc. | Director | Stock Option (right to buy) | 14K | May 14, 2025 | Direct | ||
BioAge Labs, Inc. | Director | Series D Preferred Stock | 0 | Sep 27, 2024 | Longitude Venture Partners IV, L.P. | ||
Zenas BioPharma, Inc. | Director | Series B Convertible Preferred Stock | 0 | Sep 16, 2024 | Indirect | ||
Zenas BioPharma, Inc. | Director | Series C Convertible Preferred Stock | 0 | Sep 16, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JAZZ | Jazz Pharmaceuticals plc | Aug 7, 2025 | 2 | -$201K | 4 | Aug 11, 2025 | Director |
VERA | Vera Therapeutics, Inc. | Jun 23, 2025 | 4 | $5.28M | 4 | Jun 25, 2025 | Director |
ZBIO | Zenas BioPharma, Inc. | Jun 10, 2025 | 1 | $0 | 4 | Jun 12, 2025 | Director |
BIOA | BioAge Labs, Inc. | Jun 5, 2025 | 1 | $0 | 4 | Jun 9, 2025 | Director |
VERA | Vera Therapeutics, Inc. | May 14, 2025 | 1 | $0 | 4 | May 16, 2025 | Director |
BIOA | BioAge Labs, Inc. | Sep 25, 2024 | 4 | $7.2M | 4 | Sep 27, 2024 | Director |
BIOA | BioAge Labs, Inc. | Sep 25, 2024 | 0 | $0 | 3 | Sep 25, 2024 | Director |
ZBIO | Zenas BioPharma, Inc. | Sep 12, 2024 | 8 | $7.48M | 4 | Sep 16, 2024 | Director |
ZBIO | Zenas BioPharma, Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | Director |
JAZZ | Jazz Pharmaceuticals plc | Aug 2, 2024 | 1 | $0 | 4 | Aug 6, 2024 | Director |
VERA | Vera Therapeutics, Inc. | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
JAZZ | Jazz Pharmaceuticals plc | Aug 11, 2023 | 2 | -$171K | 4 | Aug 15, 2023 | Director |
VERA | Vera Therapeutics, Inc. | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | Director, 10%+ Owner |
VERA | Vera Therapeutics, Inc. | Feb 6, 2023 | 1 | $12M | 4 | Feb 8, 2023 | Director, 10%+ Owner |
JAZZ | Jazz Pharmaceuticals plc | Nov 22, 2022 | 3 | -$1.05M | 4 | Nov 25, 2022 | Director |
JAZZ | Jazz Pharmaceuticals plc | Aug 5, 2022 | 2 | -$166K | 4 | Aug 9, 2022 | Director |
APTX | Aptinyx Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
VERA | Vera Therapeutics, Inc. | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director, 10%+ Owner |
VERA | Vera Therapeutics, Inc. | Feb 10, 2022 | 1 | $5M | 4 | Apr 5, 2022 | Director, 10%+ Owner |
JAZZ | Jazz Pharmaceuticals plc | Aug 18, 2021 | 1 | $276K | 4 | Aug 20, 2021 | Director |
JAZZ | Jazz Pharmaceuticals plc | Jul 29, 2021 | 1 | $0 | 4 | Aug 2, 2021 | Director |
APTX | Aptinyx Inc. | May 27, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |
VERA | Vera Therapeutics, Inc. | May 18, 2021 | 3 | $10M | 4 | May 18, 2021 | Director, 10%+ Owner |
VERA | Vera Therapeutics, Inc. | May 13, 2021 | 1 | $0 | 4 | May 17, 2021 | Director, 10%+ Owner |
VERA | Vera Therapeutics, Inc. | May 13, 2021 | 0 | $0 | 3 | May 13, 2021 | Director, 10%+ Owner |